VivoSeq
Other

PONV

0

Pipeline Programs↗

2

Active Trials↗

1

Companies Involved↗

PONV is an early-stage landscape with 0 programs across 1 company. The most active players are Jyoti Pandya.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

J

Jyoti Pandya

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

5

clinical trials

Unknown status2 · 40%
Recruiting2 · 40%
Completed1 · 20%

Clinical Trials

Trial Activity

The Effects of Anesthetic Techniques and Palonosetron Administration on the Incidence of PONV
Completed·—·Phase 4·NCT02809378·150 enrolled
The Effect of PCA on PONV After Microvascular Decompression
Unknown status·SSeoul National University Hospital·N/A·NCT05189704·94 enrolled
PALONOSETRON X FOSAPREPITANT IN PONV
Unknown status·HHospital Federal de Bonsucesso·Phase 4·NCT03586817·100 enrolled
TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients
Recruiting·ZZhejiang University·N/A·NCT07480785·780 enrolled
The Effect of Transcutaneous Electric Acupoint Stimulation on Post-operative Nausea and Vomiting After Spinal Surgery
Recruiting·—·Preclinical·NCT03187535·72 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)